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Background: It is acknowledged that the success and uptake of eHealth improve with the involvement of users and stakeholders
to make technology reflect their needs. Involving stakeholders in implementation research is thus a crucial element in developing
eHealth technology. Business modeling is an approach to guide implementation research for eHealth. Stakeholders are involved
in business modeling by identifying relevant stakeholders, conducting value co-creation dialogs, and co-creating a business model.
Because implementation activities are often underestimated as a crucial step while developing eHealth, comprehensive and
applicable approaches geared toward business modeling in eHealth are scarce.
Objective: This paper demonstrates the potential of several stakeholder-oriented analysis methods and their practical application
was demonstrated using Infectionmanager as an example case. In this paper, we aim to demonstrate how business modeling, with
the focus on stakeholder involvement, is used to co-create an eHealth implementation.
Methods: We divided business modeling in 4 main research steps. As part of stakeholder identification, we performed literature
scans, expert recommendations, and snowball sampling (Step 1). For stakeholder analyzes, we performed “basic stakeholder
analysis,” stakeholder salience, and ranking/analytic hierarchy process (Step 2). For value co-creation dialogs, we performed a
process analysis and stakeholder interviews based on the business model canvas (Step 3). Finally, for business model generation,
we combined all findings into the business model canvas (Step 4).
Results: Based on the applied methods, we synthesized a step-by-step guide for business modeling with stakeholder-oriented
analysis methods that we consider suitable for implementing eHealth.
Conclusions: The step-by-step guide for business modeling with stakeholder involvement enables eHealth researchers to apply
a systematic and multidisciplinary, co-creative approach for implementing eHealth. Business modeling becomes an active part
in the entire development process of eHealth and starts an early focus on implementation, in which stakeholders help to co-create
the basis necessary for a satisfying success and uptake of the eHealth technology.
(JMIR Res Protoc 2015;4(3):e104)   doi:10.2196/resprot.4519
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Implementation is necessary to promote the systematic uptake
of research findings and other evidence-based practices into
routine practice and to improve the quality and effectiveness of
health services and care [1]. Attention for evaluating the
implementation of eHealth has steadily grown in the last 5 years
[2]. Despite this increased attention for implementation, little
attention has been given to effects on roles and responsibilities,
risk management, engagement of professionals, and transparency
of potential benefits of eHealth [2]. Therefore, many
implementations are not complete enough when technology
“goes live” and its anticipated success is rather a lottery than
an actually preplanned implementation. In fact, Black et al [3]
concluded in their systematic review that many eHealth projects
provide little evidence for actually improving outcomes or being
cost effective. Implementation of eHealth has almost universally
proven to be more complex and time consuming than anticipated
[3]. In addition, many eHealth researchers assume that
implementation is an ex-post activity and start preparing
implementation when a technology is nearly finished [4]. Many
eHealth projects suffer from the “field of dreams” syndrome
with the expectation that users will show up as soon as the
technology is made available, yet end up having little support,
no plans for sustainability, poor uptake, and unknown added
value to stakeholders [4,5]. The implementation should not be
treated as an afterward necessity, nor treated subordinately to
the design of eHealth technology. “Innovation is not just about
technology anymore” [6], and therefore, a well-prepared
implementation is just as important as a well-designed eHealth
technology.
Business Modeling
In a previous viewpoint paper, we had introduced business
modeling as a possible approach to guide the development and
implementation of eHealth [4]. Business modeling fosters a
ground for dialog regarding the perceived added value and
purpose of an eHealth technology [7]. The resulting business
model depicts how an organization creates, delivers, and
captures value [8]. Such a model can be used as a narrative to
explain new ideas [9]. With business modeling, we use this
narrative to discuss, plan, and operationalize an implementation
of eHealth. Using stakeholder identification, stakeholder
analysis, and value co-creation dialog, relevant values can be
discussed and then modeled as a business model.
The Center for eHealth Research (CeHRes) road map (Figure
1) introduces eHealth development as a holistic approach
integrating eHealth technology design with business modeling
for implementation [4]. The road map consists of the following
5 phases: contextual inquiry, value specification, design,
operationalization, and summative evaluation. The road map
advises research activities that support eHealth research in each
of these phases. This paper expands on this road map by
demonstrating the research activities that we apply for business
modeling.
Figure 1. Center for eHealth Research road map.
Stakeholder Involvement
Coiera [10] stressed the importance of sociotechnical design in
health care. In his paper, he claimed that instead of technology,
the social system surrounding that technology should be the
central focus. Attention to sociotechnical factors is important
to maximize the likelihood of successful implementation and
adoption [3]. Academic interest in stakeholder theory started in
the late 1970s in the fields of public policy making and business
management. The most acknowledged definition for a
“stakeholder” in stakeholder theory was established by Freeman
as “everyone who affects or is affected by—in this case—the
eHealth technology” [11]. A stakeholder analysis aims to
evaluate and understand stakeholders from the perspective of
an organization to determine their relevance to a project or
policy [12]. In 2004, Bryson [13] reviewed 15 stakeholder
methods to identify and analyze stakeholders. Although this
review described step-by-step instructions for analysis
techniques, these techniques focus strongly on expert-driven
stakeholder classification without “true involvement” of
stakeholders. To sum up, there is adequate information on
expert-based stakeholder identification, yet methods or ideas
on “how” to involve stakeholders (eg, users, developers,
suppliers) as active partakers in stakeholder analysis and further
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co-creation are less established. Likewise, in implementation
research for eHealth, the involvement of stakeholders is still
relatively unexplored.
Aim of This Paper
This paper presents an approach for implementing eHealth with
a strong accent on stakeholder involvement. We demonstrate
our business modeling research and stakeholder-centered
analysis methods in an example case, its added value to
implementing eHealth, and conclude with a step-by-step




In a learning-by-doing approach to form our business modeling
research, we applied various stakeholder-centered analysis
methods in an example case study with a strong focus on
discovering how stakeholders can best be involved in business
modeling. These stakeholder-centered analysis methods are
based on stakeholder theory, existing business modeling tools,
and paradigms from human-centered design. In the “Methods”
section, we present a theoretical overview for each
stakeholder-centered analysis method followed by a practical
application as an example and reflections on their application.
Example Case: Infectionmanager
The European Union stimulates the mobility of their citizens.
Similarly, in health care an increasing number of patients and
health care professionals cross the borders and seek or offer
health care services abroad. “EurSafety Health-net” has the
primary goal to address patient safety in a cross-border context.
The EurSafety Health-net consists of 5 “Euregios” or 38
geographical regions, totaling 19.2 million citizens. In these
regions, 32 public health organizations and over 300 hospitals
participate in the project. Our involvement in this project focuses
on developing an Internet-based platform for cross-border
infection prevention and control, called “Infectionmanager”
(Figure 2). Infection prevention and control is a broad field, and
therefore, our eHealth project mainly focuses on antibiotic
prescription in hospitals. A change in prescription behavior is
urgent, as up to 30-50% of the prescribed antibiotics are either
inappropriate or even unnecessary and thereby harming the
effectiveness of these antibiotics [14]. Intervening antibiotic
use with antibiotic stewardship (ASP) interventions can be a
step in curbing antibiotic resistance and hospital-acquired
infections, and these can subsequently improve patient safety
and reduce costs [15].
The Infectionmanager website is a platform designed to offer
eHealth applications that support multiple crucial steps in the
antibiotic therapy process and targets multiple, different users
and stakeholders. The platform offers eHealth applications with
information, decision support, and an overview of the ongoing
research and development concerning the platform [16-18]. It
targets stakeholders in infection control with currently a specific
focus on stakeholders who deal with ASP in hospitals.
The Infectionmanager case is an example of a typical complex
eHealth project. First, there is a multitude of stakeholders with
diverse stakes, and therefore, an excellent opportunity to try
methods for stakeholder involvement. Second, the development
options were unlimited, allowing very open discussions with
stakeholders to co-create possible eHealth applications and ideas
for an implementation. Lastly, the complexity is influenced
further by the novelty of ASP in the Netherlands and the novelty
of exploring possible eHealth opportunities. Infectionmanager
has been researched and developed according to the CeHRes
road map [4].
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Figure 2. Homepage of Infectionmanager.
Stakeholder-Centered Analysis Methods
Involvement of stakeholders changes over time in the research
process. In the beginning of an eHealth project, the analysis
focuses on finding the right stakeholders and discussing global
problems and opportunities, whereas in the later stages of the
project, certain opportunities are combined into a possible
eHealth technology and the implementation research moves on
to value co-creation with topics that deal with added value,
feasibility, sustainability, and costs-benefit issues.
In this section, we present each stakeholder-centered analysis
method as listed below. First, we give a short summary of the
theoretical background of used methods, followed by the
practical application in our example case. We conclude each
method with some gaps and lessons learned from use and
experience.
Stakeholder Identification
Every eHealth project will have its own unique stakeholder
landscape that needs to be understood [4]. As a first step, before
analysis of or with stakeholders can take place, all relevant
stakeholders need to be identified. We noticed that stakeholder
analysis methods focus more on classification and categorization
than identification. Identifying a complete list of the right
stakeholders is very crucial for all further analysis. Therefore,
the identification step is very important and it is remarkable that
it is not described in depth. Many authors consider stakeholders
as a default product of a nonexplained identification process
[19].
We explored the following 3 approaches to identify stakeholders
in an eHealth project: a literature scan/review, expert
recommendations, and snowball sampling of stakeholders. These
methods are not mutually exclusive and should be integrated
as a mixed-method approach for optimal results.
Stakeholder Identification Method Number 1:
Literature Scan/Review
In Theory
There are 2 ways to identify stakeholders with literature:
• Identify stakeholders in stakeholder theory. This can result
in a list of general types of stakeholders or stakeholders
specifically in relation to eHealth.
• Identify stakeholders mentioned in literature on similar
(eHealth) interventions.
Ballejos and Montagna [19] recommend starting with identifying
stakeholder types [19]. These types of stakeholders can be very
diverse, depending on the desired level of detail. Table 1 lists
some literature examples from stakeholder’s theory of possible
different stakeholders types that can be relevant for eHealth
research [19-26]:
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Table 1. Overview of stakeholder types in literature related to eHealth.
Identified stakeholder typesResearch focus/settingStudy
Clients, customers, business/subject experts, future idea specialists, current
system specialists, clerical users, technical users, potential users, sales spe-
cialists, marketing specialists, aesthetics specialists, graphics specialists,
usability specialists, safety specialists, security specialists, cultural special-
ists, legal specialists, environmental specialists, maintenance specialists,
packaging designers, manufacturers, product installers
Stakeholder roles in information
technology
Volere template [24]
Competitors, related health care organizations, government regulatory/li-
censing agencies, private accreditation associations, professional associa-
tions, unions, patients, third-party payers, hospital suppliers, media, financial
community, special interest groups, religious organizations, local commu-
nity, nonmanagement medical staff, hospital board, parent companies/orga-
nizations, stockholders/taxpayers/contributors, management
Stakeholders in a typical, large hospi-
tal
Wolper [26]
Users, developers, regulators, decision makers (with possible client, supplier,
and satellite stakeholders for each of the above baseline stakeholders)
Baseline stakeholders in requirements
engineering
Sharp et al [25]
Developer, maintenance operator, operational support, normal operator,
interfacing systems, sponsor or champion, functional beneficiary, purchaser,
consultant, political beneficiary, financial beneficiary, negative stakeholders,
regulators, the public
Product-centric onion modelAlexander [20]
Acceptors, providers, supporters, and controllersHealth care actors involved in the
adoption of information systems
Mantzana et al [22]
Service customer, payer of service, responsible for referral, competitor,
supplier of goods, supplier of services, supplier of information, government,
and community
A total of 4 key stakeholder types
with subtypes for eHealth
Mettler et al [23]
Beneficiaries (functional, financial, political, sponsors), negatives, respon-
sibles, decision makers, regulators, operators, experts, consultants, develop-
ers
Stakeholder roles (internal or exter-
nal)
Ballejos and Montagna [19]
Beneficiaries, central government agencies, Ministry of Health, local gov-
ernments, financiers, civil society organizations, health governing boards,
provider organizations, professional organizations and health workers,
unions, suppliers
A total of 11 stakeholder categories
in health care
Hyder et al [21]
Table 1 demonstrates that the stakeholder types can differ for
each chosen focus and that multiple focuses can be used to be
thorough in the stakeholder identification. Still, these
stakeholders are only stakeholder types, and therefore, a
researcher still has to identify which of these stakeholder types
are present and more importantly, identify who the exact
stakeholders are for each stakeholder type. For example, relevant
stakeholder types can be “users” or “service customers,” but
are they patients or specialists? What kind of patients? Which
of these patients are included in research and which ones are
not?
The second option is to identify stakeholders in the literature
on similar interventions. These interventions do not have to be
technology per se but are implemented in the same domains as
the intended eHealth technology. In this case, very precisely
defined stakeholders can be found by looking at the context
[27]. This requires sufficient prior knowledge of the domains
(medicine, policies, technological) and a clear idea of the goals
of the intended eHealth technology. Literature can then be
reviewed for mentioned stakeholders (usually professions or
organizations); for example, by ranking their occurrence in each
publication.
Example Case
When starting with Infectionmanager, our research team decided
that ASP was a key intervention for infection control in hospitals
and that our main interest was to start exploring eHealth
possibilities. We conducted a quick scan literature review on
ASP to list possible stakeholders who are relevant for ASP [28].
We performed a quick scan (so not a systematic review or
similar strict methods) as this list would provide a general idea
of stakeholders who should be involved in our ASP research.
We ran a query on “antibiotic stewardship” and selected papers
of most cited or key literature from that research domain. We
scanned 12 key papers and noted every mentioned stakeholder
in these papers. This resulted in a complete list of stakeholders
in international hospitals based on the literature scan of ASP.
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Textbox 1. List of antibiotic stewardship stakeholders identified in a hospital after a literature scan.
• (Clinical) pharmacists
• Epidemiologists
• Head of pharmacy department
• Infection control nurses












• A (quick) literature scan is a good starting point to start
with stakeholder identification. It is a fast way to draft a
list of stakeholders who may be relevant for further
stakeholder identification and later stakeholder analysis.
• An inventory of stakeholder types can be useful as an extra
check to see if certain stakeholder types are missing on the
stakeholder list or left out for a clear reason.
• Start with a manageable amount of key publications using
a simple query in your research subject and list or tally
mentioned stakeholders. With 10-20 publications, that
stakeholders list will saturate.
• New, innovative health care interventions have limited
available literature, especially in an academic context. In
our example case, little literature was available for
eHealth/health care technology in the field of prescribing
antibiotics and stewardship.
• A potential danger with international literature is that it
describes various different health care contexts and thus
identified stakeholders may not be relevant for local health
care systems. To illustrate with examples from our project:
Microbiologists in Francophonic countries are called
“bacteriologists,” and thus, are not 2 different stakeholders;
or “infectious disease physicians” do not exist as-is in the
Dutch health care system and the closest comparable
profession would be an “infectologist,” which we learnt
afterward through validation of our stakeholder list with
experts.
• Policies, (clinical) protocols, and documents are very
relevant sources to take into consideration as literature for
stakeholder analysis [29], especially when the eHealth
intervention is targeted toward supporting tasks performed
by health care professionals. Obtaining these protocols and
documents requires access via experts or stakeholders who
use them.
Stakeholder Identification Method Number 2: Expert
Recommendations
In Theory
After exploring stakeholders from a theoretical perspective, the
next step is to introduce a practical perspective. Most stakeholder
analysis methodologies seem to prefer an expert-driven
approach. According to Bryson [13], the “basic stakeholder
analysis technique” suggests that the planning team (ie, the
eHealth research team in eHealth context) brainstorms which
stakeholders should be included for analysis. Depending on the
composition of the planning team, one can also ask (external)
field experts to nominate stakeholders [21]. The goal of this
brainstorming session is to make a complete overview of
relevant stakeholders to the eHealth project.
Example Case
We planned 2 brainstorming rounds. The first round started by
using specific software that allowed to visualize stakeholder
mapping. Our planning team consisted of eHealth researchers
and infection control experts affiliated with our EurSafety
Health-net project. We conducted 22-hour brainstorming
sessions to visualize an overview of stakeholders relevant for
infection control and subsequently Infectionmanager. In this
early phase of our research, we looked at infection management,
which had a broader scope than ASP specifically. We also
categorized the stakeholders in stakeholder groups with the
mapping software. The Infectionmanager was the central point
of discussion, and so, the central question was “Which people
or organizations have an influence on Infectionmanager?” And
subsequently, “Which people or organizations are influenced
by Infectionmanager?.” Using these 2 questions, we
brainstormed a stakeholder map. In this visual way of
brainstorming, the network and relationships of stakeholders
become clear. For example, the stakeholder “care recipients”
can be categorized into 3 different types of care recipients with
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different roles toward Infectionmanager. Or, as another example,
we listed possible commercial third parties, possible hospitals,
and so on. The visualization aspect of this approach helps to
draft a visual representation of the possible stakeholder map,
which makes the brainstorming process less abstract and more
comprehensive for all participants in the brainstorming team.
A global overview of our stakeholder map can be seen in Figure
3.
The second brainstorming round targeted “ASP” more
specifically and was a continuation of the stakeholders found
with the quick literature scan as described in the previous
method. Our team of eHealth researchers asked an infection
control expert working at a pilot hospital to help us transpose
the theoretical list of (international) stakeholders to stakeholders
present at a pulmonary ward. We chose this pulmonary ward,
as these wards have a relatively high use of antibiotics and
relatively low multimorbidity. In the focus group, we
brainstormed about every stakeholder on the list and the
stakeholder’s possible role in ASP, Dutch analogous profession,
and whether that stakeholder was available in the pulmonary
ward. Later, for further stakeholder analysis, we organized a
focus group with the following stakeholders [30]: clinical
microbiologists, pharmacists, (chest) physicians, residents,
nurses, nurse manager, ward manager, and staff members of
management.
Figure 3. Stakeholder map relevant for infection control and subsequently Infectionmanager.
Gaps/Lessons Learned
• Brainstorming with experts is a useful method to bridge the
theoretical list of stakeholders with the relevant practice.
Experts are active in the field, so a researcher needs to make
use of their firsthand knowledge.
• Visualization of the stakeholder map helps making the
discussion of relevant stakeholders less abstract and fosters
the collaboration and discussion. A map is quick to
comprehend and easier to share than long lists, for example.
It also visually structures the mentioned stakeholders.
• The more experts involved, the better. Experts are limited
to their profession and background and may not know all
parts of the stakeholder map. For example, a microbiologist
knows all about the laboratory and microbiological
diagnosis but has little insight into the daily routine of a
nurse during ASP.
• Structure in the focus group is important. Prevent vociferous
stakeholders who hijack the session for sharing their views
only. Give every stakeholder adequate time and attention.
• Involving more experts also increases validation and paints
a broader picture.
• Be open-minded to the stakeholders that experts suggest
despite prior knowledge from the literature. In case of
questionable or unclear stakeholders, note them and ask
why they are relevant and discuss/evaluate their relevance
later with other experts.
Stakeholder Identification Method Number 3:
Snowball Sampling With Stakeholders
In Theory
Both literature and expert recommendations can still miss certain
stakeholders who may be important to the project. A final step,
once a list of stakeholders is ready, is to ask these stakeholders
JMIR Res Protoc 2015 | vol. 4 | iss. 3 | e104 | p.7http://www.researchprotocols.org/2015/3/e104/
(page number not for citation purposes)
van Limburg et alJMIR RESEARCH PROTOCOLS
XSL•FO
RenderX
to complete the list. The added value of this step is to validate
the list of stakeholders from a stakeholder’s perspective and a
last chance to identify missing stakeholders. Snowball sampling
is a technique where existing participants recruit future
participants among their acquaintances. In terms of stakeholder
snowball sampling, stakeholders can be asked who the
stakeholders are, or, in case of an already available list, which
stakeholders are important and which ones are missing.
Snowball sampling is one of the common methods used for
stakeholder identification [31].
Example Case
In earlier brainstorm sessions (mentioned as a “previous
method”), we drafted an initial list of stakeholders in infection
control. These stakeholders were sent a questionnaire in which
they could rank the importance of stakeholders on our
stakeholders list and suggest missing stakeholders [32]. This
eventually resulted in the stakeholder map of infection control
as depicted in Figure 4. What is interesting is that this map
contains some different stakeholders than the ones mentioned
by experts and us but above all, it has a broader focus than the
expert-based map in Figure 3. For example, our research mostly
focused on stakeholders related to infection control in hospitals;
yet, these stakeholders also pointed out that dental care and
livestock industry deal with infections and antibiotics and are
very relevant for infection control as a whole. Therefore, despite
having a focus on hospitals (as outlined in Figure 3), there are
a lot more other infection control stakeholders to involve in the
stakeholder analysis.
As mentioned in the “Stakeholder Identification Method Number
2: Expert Recommendations” section, we further focused on
ASP as a key intervention for infection control inside hospitals.
Thus, we planned a focus group with stakeholders at a
pulmonary ward [30].We also applied snowball sampling to
this focus group, and the existing stakeholders agreed that we
should additionally contact dieticians, cleaning personnel, and
a representative of the information technology department as
they may have an influence on ASP.
Figure 4. Example of all the stakeholders relevant for infection control.
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• Stakeholders have the most direct firsthand experience
within the subject domain and thus are crucial in stakeholder
identification.
• Snowball sampling is suitable for identifying missing
stakeholders. In our case, for example, we identified neither
dieticians nor cleaning personnel as relevant stakeholders
for ASP via literature.
• Questionnaires are the most convenient method for snowball
sampling a complete list.
• Focus groups allow interaction with stakeholders, to
iteratively assess conclusions from stakeholders and
researchers. Yet, focus groups can be difficult to organize,
especially when they consist of a high number of
stakeholders. The focus group needs to have something for
the stakeholders to be willing to schedule it.
Stakeholder Analysis
After stakeholders are identified, they can take part in the
stakeholder analysis. Not every identified stakeholder will be
equally important to the implementation of the eHealth
technology [4]. In addition, it takes time and resources to interact
with every single stakeholder, and therefore, it is recommendable
to work toward a selection of key stakeholders. Narrowing the
list of stakeholders requires applying some acceptable and
justifiable sorting criteria [33]. Again returning to the review
by Bryson [13], there are a plethora of stakeholder analysis
methodologies to classify stakeholders. In this paper, we
demonstrate our application of the basic stakeholder analysis,
stakeholder salience (Mitchell’s classification), and
ranking/analytic hierarchy process (AHP) method.
Stakeholder Analysis Method Number 1: Basic
Stakeholder Analysis
In Theory
The basic stakeholder analysis method involves brainstorming
expert-based opinions on behalf of each stakeholder [13]. The
research team and/or experts can give a global impression from
the stakeholders’ point of view about what the expectations can
be for each possible stakeholder. The analysis aspect behind
this method is that a stakeholder with many (important)
expectations will most likely be important to the project
throughout development. In terms of business modeling, these
expectations are related to “values” that we will discuss more
in depth later in this paper.
Looking from a research team stance, this overview of possible
expectations also allows a first impression on the value
proposition possibilities [34]. A value proposition is “the value
created for users by the offering based on technology” [35]. In
other words, it describes what added value a technology has to
offer, as well as possible services around the technology. This
value proposition will be the basis for the design and
implementation of the eHealth technology.
Example Case
During our brainstorming sessions early on in our research, we
examined with experts what possible values each stakeholder
could express. We used the same stakeholder mapping software
by Inpaqt again to make a value tree for every stakeholder.
Value trees can be used to identify a hierarchy of values [36].
For each stakeholder, our project team discussed possible value
expectations of Infectionmanager. The next step was to assign
a level of importance to these value expectations. We assigned
a number between 1 and 5 for each value and its attributes. Not
only can this method prioritize stakeholders with many
(high-ranking) value expectations, but it can also provide an
overview of possible value needs and how these values and their
attributes are linked with each other. In this example, providing
information for high-risk patients with the Infectionmanager
(the attribute “information”) would not only affect the value
“be informed” but also the values “feeling better,”
“empowerment,” and “peace of mind”.
In Figure 5, we show an example of a value tree with possible
values (diamonds)—expectations of a high-risk patient
group—as well as attributes (blue boxes) that detail these values.
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Figure 5. Example of value tree with possible values expectations and attributes for high-risk patients.
Gaps/Lessons Learned
• This method is a start to understand who the possible
important stakeholders are and to prepare a general
impression on what to expect as value needs for the
technology and implementation.
• It helps to understand the linkage of values. For example,
the same values can be shared by multiple stakeholders or
values can influence the technology on several places and
vice versa.
• Theoretically, this “basic stakeholder analysis” method does
not truly involve stakeholders because it is done by experts.
To make this method less expert driven and more
stakeholder driven, stakeholders can partake in the
stakeholder analysis sessions as well.
• Doing this digitally can be a bit more difficult as during the
brainstorming sessions a researcher has to real-time model
while conducting the discussions, although this is very
convenient for continuing and sharing the session results.
• The analysis remains subjective and rather high level or
abstract as you try to draw an overall picture of all possible
views of all possible stakeholders with experts.
• Experts only see their part of the process, and thus, their
conceived values may be biased.
Stakeholder Analysis Method Number 2: Stakeholder
Salience
In Theory
A popular method to determine the importance of stakeholders
is the stakeholder salience approach proposed by Mitchell et al
[33]. They defined stakeholder salience as the degree to which
managers give priority to competing stakeholder claims. Salience
is based on 3 attributes that can be classified, namely, power,
legitimacy, and urgency (Figure 6). Power is defined as “a
relationship among social actors in which one social actor, A,
can get another social actor, B, to do something that B would
not have otherwise done.” Legitimacy is defined as “a
generalized perception or assumption that the actions of an
entity are desirable, proper, or appropriate within some socially
constructed system of norms, values, beliefs, and definitions.”
Finally, urgency is defined as “the degree to which stakeholder
claims call for immediate attention.” Based on the 3 attributes,
Mitchell et al [33] defined 9 possible stakeholder classes for
classification. It is out of the scope of this paper to elaborate on
each class, but in short, stakeholders who score on all 3 attributes
are definite stakeholders, and thus key stakeholders.
Stakeholders who score 2 of 3 are relatively dominant,
dependent, or dangerous stakeholders and should also be
included. Stakeholders who only score 1 of 3 are dormant,
discretionary, or demanding stakeholders.
Stakeholder salience can be determined by experts in the
aforementioned expert brainstorm sessions or project meetings,
or by stakeholders themselves using a questionnaire, one-on-one
interviews, or a focus group.
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Figure 6. Stakeholder salience diagram according to Mitchell et al [34].
Example Case
We first arranged expert interviews to rate the infection control
stakeholders, according to Mitchell’s salience. We asked 2
infection control experts to rate stakeholders on whether they
have power, legitimacy, and urgency. We then sent a
questionnaire to stakeholders who according to experts were
the “definite stakeholders” [32]. Table 2 shows a fragment of
our salience assessment.
Practically, we learnt that these 3 attributes of salience (ie,
power, urgency, and legitimacy) are difficult and had to be
explained in more general, nonbusiness-specific terms to the
experts and stakeholders: We explained power as “the level of
influence a stakeholder has in infection control.” Legitimacy
was explained as “the level in which a stakeholder needs to be
legally, morally, or contractually involved in infection control.”
And finally, urgency was “the priority or necessity of the
stakeholder in infection control.” It is crucial to keep these
terminologies and definitions consistent [31].
After comparing the stakeholder salience expressed by
stakeholders and by experts, we could validate and draw
consensus in both results [32]. The differences were that experts
mentioned the Ministry of Health as important and stakeholders
did not, and stakeholders found the National Institute for Public
Health and the Environment, nurses, and veterinarians more
salient. We added these 3 to our final definite stakeholders list.
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• This salience approach is the most commonly used method
to assess the importance of stakeholders, and thus, can be
seen as a widely acknowledged method. It is also a
commonly used method for stakeholder assessment in
eHealth research.
• Determining which stakeholders are definite
stakeholders—in-turn important for implementation
research—is feasible using Mitchell’s stakeholder salience.
This is especially true when it is necessary to bring the
number of stakeholders down to a manageable number to
actively involve them in the implementation research.
• The 3 salience attributes (ie, power, legitimacy, and
urgency) are difficult concepts. They might overlap and as
they are explained in business terms, they are also complex
to properly explain to stakeholders. The researchers have
to be consistent in the explanation and make sure the
stakeholders understand the difference.
• Subsequently, there is also a risk that stakeholders do not
fully comprehend the attributes and give answers based on
gut feelings or what they expect should answer. Therefore,
as the researcher, one needs to be alert and ask for short
elaborations.
• The stakeholders who score all 3 attributes of salience are
important stakeholders to be involved in the project;
however, with a high number of stakeholders, it is important
that further analysis is carried out to identify those
stakeholders who scored 2 (or maybe even 1) of 3 attributes
and include them in the list. This depends on the number
of stakeholders and keeping it manageable for research
purposes.
Stakeholder Analysis Method Number 3:
Ranking/AHP
In Theory
Another way to classify the importance of stakeholders is by
attributing an importance score to stakeholders. This scoring or
ranking can be done in several ways. In our research, we used
a 5-point scale and a derivative of AHP [37] as 2 methods for
ranking:
• The 5-point scale is very straightforward. Hyder et al [21]
proposed to articulate the power or importance of
stakeholders using a 5-point scale. Experts or stakeholders
themselves can assign 0 (not important) to 5 (very
important) points to a list of stakeholders. Similar methods
can deviate from the scale, eg, a 9-point scale [36] but
different scales seem arbitrary.
• A mathematically more sophisticated method for ranking
is Saaty’s AHP [37], which is also applied in health care
research [38]. It is out of the scope of this paper to explain
how AHP works in full detail. In short, AHP is frequently
used in the analysis for decision making. In AHP, the
hierarchic relation (an eigenvector approach) of stakeholders
weights their relative importance. Saaty’s AHP technique
becomes especially interesting when the hierarchy expands
by also mapping values and attributes to stakeholders (as
seen in the value trees in Figure 5). Using a mathematical
construction, the number of values and hierarchic
relationships determine a weighted outcome for every
stakeholder, value, and attribute. It is a sophisticated
method, but in our experience the most thorough analysis
currently available.
Example Case
The software tool we used for ranking the stakeholders also
allowed for a 0-5-point scale to rate the importance of
stakeholders. We applied a simple hierarchic calculus based on
the value trees. For example, a value with 5 points from a
stakeholder with 5 points would get 25 points, a value with 5
points from a stakeholder with 2 points would score 10 points.
This is slightly different to Saaty’s AHP method as we did not
apply relative weights and eigenvectors to avoid overcomplexity
in the calculations. We assigned the ranking in a brainstorm
session with experts as can be seen in Figure 7 and we did the
same to values (as already shown in Figure 5). We did not rank
stakeholder or values in an interactive session with stakeholders
themselves in our example case, as it would be unfeasible to
organize all stakeholders together.
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Figure 7. Expert-based stakeholder ranking for infection control portal.
Gaps/Lessons Learned
• Ranking with numbers is a simple yet effective way to
quantify and classify the importance of stakeholders.
• AHP can overkill and in practice a simpler calculation of
[stakeholder× value × attribute] might be a good alternative.
• The 0-5-point scale is still an arbitrary quantification that
is interpreted by stakeholders or experts. For example, what
makes a stakeholder a 2 or a 3? The best way to get
satisfying results is by validation by either asking multiple
stakeholders to rank or to work toward a consensus.
• We did not choose to fully use AHP because it has to be
done very thorough, as the hierarchy will determine the
importance through eigenvectors. If 1 stakeholder or value
is lacking, results may become counterintuitive [37]. More
research is needed on this.
Value Co-Creation Dialog
After the stakeholders are analyzed and it is known whose input
to the implementation of the eHealth technology is more
important than others, it is time to start with value co-creation.
We define a “value” as an ideal or interest a (future) end user
or stakeholder aspires to or has [29]. These values can be further
detailed into “attributes.” An attribute is a summary of the need
or wish that is spoken out by the (future) end user or stakeholder
[29]. Still, “value” remains a difficult concept to concisely
communicate as this can elicit philosophical debates on what
is good and bad. The eventual eHealth technology and its
surrounding services to embed it properly in its intended care
setting all encompass the value of the eHealth technology.
Value co-creation is a joint activity involving customers to
identify values from their perspective [39]. In other words, with
co-creation, stakeholders get an active dialog and co-design the
development process of eHealth. In addition, for most
stakeholders, value is also a difficult business concept to grasp.
One cannot simply ask, “Ok, what value do you expect?” In
fact, in most cases the stakeholders cannot even grasp what the
technology will be like, nor how it can be used. The researcher
has to prepare relevant value co-creation questions and have a
discussion with all key stakeholders about their value
expectations.
We herein demonstrate 2 possibilities as to how we conducted
these value co-creation dialogs: process analysis and stakeholder
interviews using the business model canvas.
Value Co-Creation Dialogs Method Number 1: Process
Analysis
In Theory
To co-create value, Prahalad and Ramaswamy [39] noted that
a joint problem definition and problem solving are required. To
facilitate this process, the authors recommend the DART
method:
• have “dialogs” with stakeholders about their experiences;
• get “access” to information;
• assess “risks” and benefits with stakeholders; and
• be “transparent” with information.
We combined these 4 with ideas of the contextual inquiry of
our road map that recommends performing interviews or focus
groups using a scenario-based problem analysis. Focus groups
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offer an opportunity to obtain insights regarding the experiences,
observations, and opinions of group members [40]. As Prahalad
and Ramaswamy [39] point out, to understand the individual
experiences for co-creation, the problem analysis, inspired by
action research, sense making [41], and previous research [42],
should encompass a general discussion of the entire process,
including individual tasks, information, and communication
needs, as well as the problems experienced and bottlenecks.
Example Case
We organized a workshop for a focus group in a pulmonary
ward, inviting stakeholders relevant for ASP [30]. In this
workshop, we asked stakeholders about the problems they
experienced (general), process bottlenecks (coordination,
communication), and information needs (communication,
documentation). Stakeholder role playing (enact a situation or
process) is mentioned as a possible way to determine importance
and value needs of stakeholders [43]. Thus, we started a quick
role play of “Who does what?” with the process behind antibiotic
prescription for a complex patient. For each topic, we prepared
a poster on which stakeholders could stick written Post-its with
possible values, and group them in importance. The main
problems that were mentioned were regarding the information
flow of patient information and insufficient cooperation and
consultation between the attending physician and microbiologists
again due to inefficient information sharing as well as due to
unstructured procedures for consultation. Some stakeholders
also noted that an insufficient knowledge of (new) procedures
or application of medication might cause problems [30]. An
interesting find was that nurses could play a big role in ASP.
Gaps/Lessons Learned
• Value creation with a focus group approach allows for a
discussion, and therefore, when talking about processes,
problems, or tasks, stakeholders can directly respond to
each other, allowing co-creation through agreement and
consensus on possible positive and negative values.
• This discussion itself can already be an eye-opening
experience for stakeholders. On several occasions, a
stakeholder admitted, “I did not know that you were
experiencing that (as a) problem,” which suggests that
discussions create more understanding for each other and
willingness for improvement or change.
• Stakeholders might not express all problems or play them
down due to the presence of other stakeholders.
• Through this approach, stakeholders will mostly discuss
problems and opportunities to change these problems. They
might not express them exactly as values but more as
attributes. In that case, after recording the focus group
sessions, researchers need to extract values from the
transcript that are relevant to the technology and its
implementation [29].
• In this step also eHealth opportunities can be discussed that
can help ideating possible eHealth technology in
collaboration with the (technical) design researchers.
Value Co-Creation Dialogs Method Number 2:
Business Model Building Blocks
In Theory
For this approach, we started with a business model as a basis
to discuss values. A business model mediates between
technology development and its intended (economic) value
creation [6,35]. In other words, it can be used to explain the
value creation logic necessary to create a successful piece of
technology. Likewise, a business model can explain the rationale
behind implementing eHealth technology [4]. The most
commonly used framework for making a business model is the
business model canvas by Osterwalder and Pigneur [8]. Their
business model consists of the following 9 building blocks:
value propositions, customer relationships, channels, customers,
key activities, key resources, key partners, cost structure, and
revenue streams. These building blocks can guide questions
regarding the necessary values for implementing eHealth.
Although Osterwalder and Pigneur [8] proposed several
questions for each building block, these are targeted toward
high-level strategic management. The trick is to transpose these
questions to the intended eHealth technology and ask which
values are necessary for that eHealth technology to be
successful.
Example Case
We took the building blocks of the business model canvas and
organized them into 4 main topics for questions on necessary
values for implementing ASP, taking the mentioned problems
and bottlenecks during the focus group into consideration when
preparing questions. Table 3 presents some questions used. Each
of the 4 topics has a central question that needs to be answered,
with several subquestions. We then organized 1-hour,
one-on-one interviews with stakeholders and used this
questionnaire as a basis for the interview.
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Table 3. Example of topics based on business model components.
ExplanationCentral questionBuilding blocks
The value proposition is basically the to-be-developed platform for ASP.
We prepared concrete questions like “What value does ASP need to deliver
to you, to your department, and to the hospital?,” “What problems does it
help to solve?,” “What technology and services can we offer to you?,”
and “What do you deem really necessary to be satisfied with ASP?”
What value should antibiotic steward-
ship (ASP) offer?
Value proposition (the technology
and its services)
Here we focused on all human interactions relevant for ASP. We asked
which stakeholders (people or organizations the stakeholder interacted
with, or should interact with for ASP). We made a list of stakeholders,
described their role briefly, and ranked their importance. We also asked
for external stakeholders who may be relevant for ASP as, in general,
stakeholders tended to respond from their internal, hospital perspective.
Who are the stakeholders?Customers, key resources, and key
partners (the stakeholders)
We asked “How can ASP be integrated with your daily routine?” Regarding
possible resources, we asked what tools, means, documents, sources, or
people were necessary for ASP and their importance. We had to steer the
stakeholder by asking specifically whether a certain technical infrastructure
is needed, what technical medium, which data flows and connections or
systems are relevant to assess the needs for eHealth technology. We also
steered by asking what knowledge is further required, in terms of support
from people or literature to have an ASP to assess what resources are
specific to ASP.
What is the required infrastructure?Key resources and key activities
(the infrastructure)
We avoided monetary discussions with stakeholders. Costs and revenues
are always a difficult subject as there may be many benefits not directly
linkable to 1 particular stakeholder. In the focus group we organized ear-
lier, stakeholders stated there is a trade-off between quality and efficiency
regarding ASP and that they should be balanced [30]. Therefore, we chose
to ask for effects and success factors. We asked what the expected effects
on patient outcomes (eg, length of stay, mortality, treatment duration, pa-
tient safety) would be and their relative importance and whether other
quality aspects not directly related to the patient are relevant. We did the
same for efficiency, and so, what are the important outcomes for efficiency
(costs, less usage of antibiotics, fewer complications, etc) and their impor-
tance.
What are the success factors?Costs and revenues (the added
values)
Gaps/Lessons Learned
• One-on-one interviews allow for in-depth analysis of
possible values and critical success factors for implementing
an eHealth technology and results in a deeper discussion
and understanding of each stakeholder’s value expectations.
Not only are values expressed, but it is also elaborated why
they are important.
• From our experience, we advise that the questions need to
be concrete enough for stakeholders to give satisfying
answers. If the questions are too abstract, the answers will
be equally abstract and thus less useful.
• It is important that the interviewer focuses on what the
technology should contribute, not design or requirements.
It is not about how they want the eHealth solution to be, it
is about the why.
Business Model Generation
As “business modeling” suggests, the eventual output is a
business model. Exact visualizations of business models are
diverse and there is no unanimous agreement on what they
exactly should look like or the level of detail they should contain
[7]. This is also why there is neither a dominant design nor many
tools available for making business models. A popular method
for visualizing a business model is the business model canvas
[8]. Although this canvas is perfect at abstracting and visualizing
key elements that should be in a business model, comprehensive
step-by-step instructions on how to retrieve the detailed narrative
for these key elements remain rather abstract and is therefore
mostly targeted at high-level strategic management. However,
existing templates or blueprints such as this business model
canvas are useful to make a model representation of an
implementation of health care technology [4]. We also used this
business model canvas as our template for a business model.
Business Model Generation Method: Business Model
Canvas
In Theory
The business model canvas (Figure 8) consists of 9 building
blocks that can describe the whole rationale of an
implementation. In the middle block is the value proposition,
the eHealth technology in this case. The top 3 blocks on the
left-hand side of the model deal with the required organizational
and infrastructural aspects, that is, the key activities, resources,
and partners. The top 3 blocks on the right-hand side deal with
who the customers/users are and how to interact with them. At
the bottom are the financial aspects. Creating and offering values
generate costs, and a revenue model is necessary to capture
value back to at least cover these costs. This canvas can be used
as an empty framework or blueprint to fill with critical success
factors that describe the implementation of an eHealth
technology.
JMIR Res Protoc 2015 | vol. 4 | iss. 3 | e104 | p.15http://www.researchprotocols.org/2015/3/e104/
(page number not for citation purposes)
van Limburg et alJMIR RESEARCH PROTOCOLS
XSL•FO
RenderX
Figure 8. Business model canvas by Osterwalder and Pigneur [8].
Example Case
We made a business model (Figure 9) filled with the values that
were concluded using the focus group and one-on-one interviews
as delineated in the previously explained value co-creation
methods. We listed critical success factors that are our
translation of expressed values and attributes.
This business model in Figure 9 gives an overview of relevant
critical success factors that determine the success of ASP and
what role Infectionmanager can play in ASP. It pinpoints critical
values that the technology needs to offer to be valuable to
stakeholders, critical values that need to be made available in
the infrastructure to guarantee feasibility, uptake, and
sustainability. This business model also gives an idea about
financial opportunities that are available to make
Infectionmanager self-sustainable. To sum it up, this business
model provides a bird’s-eye view of all critical success factors
to implement our Infectionmanager.
Figure 9. Business model canvas filled with critical success factors.
Gaps/Lessons Learned
• A business model can give an overview of the critical
success factors for implementing an eHealth technology.
• The level of detail depends on the dialogs with stakeholders,
and therefore, the completeness of the business model
depends on the (successful) completion of those earlier
research steps.
• This is still only a model that reflects a possible (maybe
even multiple) implementation. It still needs to be explained
to others and practically expanded on to put the eHealth
technology “live.”
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Stakeholder Analysis and Co-Creation of Values
Stakeholder analysis and co-creating values for a business model
with them is a progressive journey to understand the global
context and problems and to gradually work toward an in-depth,
individual dialog with stakeholders to understand what they
find important to the technology and its implementation. By
exploring several stakeholder-oriented methods as part of
business modeling as delineated in the “Methods” section,
should we have to start implementation research anew from
scratch, we would suggest the business modeling steps presented
in Textbox 2.
Textbox 2. Step-by-step guideline for stakeholder involvement for business modeling in eHealth technology implementation.
Business modeling steps for implementing eHealth technology (arranged stepwise):
1. Start with a literature review on comparable interventions to get a feeling for the domains, jargon, and global issues and stakeholders.
2. Involve 1 or 2 domain experts in the research and development team to reflect future findings, ideally experts who have an affinity with technology
and research processes.
3. Make an overview of all possible stakeholders based on literature on comparable interventions in the domain.
4. Assign stakeholder types to possible stakeholders, verify if certain types are missing and why.
5. Validate the entire overview by snowball sampling a complete stakeholder list with these key stakeholders.
6. Let experts select key stakeholders from the complete stakeholder list.
7. Organize a focus group with at least one in-person representative of each key stakeholder:
• Start with discussing each stakeholders’ role in the current processes.
• Let them complete the stakeholder list for missing stakeholders based on the process.
• Ask stakeholders to rank the importance of stakeholders, or alternatively let experts do it later.
• Discuss what bottlenecks are experienced.
• Discuss opportunities for improvement and opportunities for eHealth.
8. Summarize bottlenecks and opportunities and determine with the research team which opportunities are there for eHealth technology and whether
these fit the project goals.
9. Ideate an eHealth technology (when possible, make mock-ups or a prototype of the ideas).
10. Plan interviews with stakeholders, or if possible, multiple stakeholders of the same stakeholder type, for value co-creation dialogs for the ideated
eHealth technology.
11. Prepare the value co-creation dialog interview with questions that address all business model components (also prepare subquestions that propose
possible ideas or values on each business model component to help the interview along. Focus on what the technology should contribute to their
daily routines, not technical requirements).
12. Code transcripts of the focus groups and interviews, extract all implementation-related comments and combine all values and critical factors in
the business model canvas.
13. Discuss the resultant business model with the research team.
14. Optionally, for transparency and extra validation, explain the business model to stakeholders and let them reflect on it or write a document that
explains the implementation strategy based on the business model as the model itself may be unclear to share with the relevant stakeholders.
Gaps/Lessons Learned
To further substantiate the guideline, we conclude the following
main lessons from the gaps and lessons learned from our
implementation research, for which the aforementioned
guideline will help:
• Understanding the context beforehand is crucial to find the
right stakeholders and to understand their problems and
opportunities for eHealth. As an eHealth researcher, you
will have to familiarize yourself with the relevant domains.
In our example case, we read up on antibiotics and
microbiology literature. If the domain is not your core
expertise, involving an expert from the domain is a must
to help validating the research.
• Identifying stakeholders is easier than identifying their
stakes. Stakeholder analysis is a complex task and needs to
be done thoroughly to understand which stakeholders play
a key role in the implementation of eHealth technology.
Our advice is to discuss it with a group of stakeholder or
combine multiple analyses so that outcomes can be
compared.
• Co-creation requires incorporating multiple perspectives.
Eventually, everything is joined in an implementation.
When important stakeholders have different or even
incompatible views on the implementation, this will become
a huge problem for the technology. All effort should then
go toward finding a consensus or a workable trade-off
between values.
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• Values are tough constructs. Business modeling is about
discussing values, but stakeholders usually do not express
their views in terms of “greater goods,” but in to-the-point,
pragmatic statements of what they want or what should be
changed. It is up to the research team to interpret and
combine these statements into high-level values.
• Business models are not all about money. Health care is a
complex market in which, for example, quality of care or
patient safety can be much more important than cost savings
or maximized profits. Therefore, the values to discuss are
truly “greater goods” and not only money flows.
• An implementation is never finished. Every environment
is dynamic, so stakeholders change, business models
change, technologies change, etc. The technology needs to
be evaluated and when outcomes are getting unsatisfactory
it may be worthwhile to redo the business modeling steps




In this paper, we propose a guideline for business modeling
with stakeholder-oriented analysis methods for implementing
eHealth. The aim of this guideline is to co-create an
implementation for eHealth together with stakeholders, by
identifying and analyzing stakeholders, discussing co-creation
of value with stakeholders, and determining a business model.
Once all values are captured in a business model following the
step-by-step guide, the model can be used as a basis to
disseminate or further detail the design and implementation of
the eHealth technology.
We saw that most applications of business models in eHealth
(if applied that is) are usually based on generic, strategic models
or concocted by experts without truly involving stakeholders
in the process. In that regard, there is little to no co-creation
with stakeholders. The proposed guideline may seem a lot of
research and time consuming, but if it can avoid misaligned
plans or expectations, lack of uptake, or even design mistakes,
it should be worth to spend that time and effort in business
modeling.
Because only few frameworks or guidelines are available for
business modeling, we chose a pragmatic approach for
determining a guideline that can be used in future
implementation research. The CeHRes road map (Figure 1)
originated in the search to combine “design research” with
“implementation research” for a holistic approach for health
care technology development. Design and implementation
influence each other; hence, a holistic view that combines both
is essential for the success of health care technology [4]. Health
care technology development is a multidisciplinary process [44].
However, in the field of health care, a multidisciplinary and
participatory approach toward development is novel as many
of these projects are still expert or eminence driven. This causes
problems, as experts also are biased in how they perceive the
setting. Policymakers or management see the big picture and
understand the global problems a technology needs to address,
but still details necessary for implementation can only be
understood by talking to those who are directly influenced by
the technology.
Stakeholder analysis theory is less scarce than theory on business
modeling. In fact, there are many methods in the academic field
such as stakeholder theory, policy making, or requirements
engineering. Yet, all these possible methods have to be
combined in the context of eHealth development. eHealth brings
multiple domains of research together; thus, it calls for
experimenting with combinations of multidisciplinary research
methods. We believe this guideline is a first step toward a very
pragmatic approach to think about an implementation for
eHealth technology with the essence that stakeholders should
be involved in the entire process.
Whereas other implementation theories such as normalization
process theory [45], service, technology, organization, and
finance model [46], human, organization and technology-fit
[47] focus on advising possible factors that influence eHealth
implementation, we focused on obtaining such possible factors
from stakeholders themselves. Although the aforementioned
methods may be successful to find an implementation, we
believe that the focus on stakeholders helps to make the
technology fit their daily routines and environment in a
bottom-up approach. It basically emulates the principles of
user/human-centered design, by co-creating an implementation
with stakeholders. Instead of a top-down approach in which
experts work with a preset of possible critical factors, we apply
a bottom-up approach by extracting possible critical factors
from what stakeholders deem critical for implementation.
Considering the difficulties with implementation of eHealth as
we laid out in the “Introduction” section, we found that
describing a pragmatic approach for co-creating an
implementation with stakeholders may spur others to be more
transparent in how they did it. Instead of reinventing the wheel
or repeating the same mistakes again, eHealth projects can learn
from each other by giving more insights into the steps that were
taken to implement the technology.
Limitations
The presented guideline also has some limitations. First, this
paper only demonstrated 1 example case. We applied individual
methods or parts from the guideline in parallel to eHealth
research based on our CeHRes road map [4,42,48-50], yet
further validation of its generic use as a complete framework
for other eHealth projects is necessary. It is certainly worthwhile
to test the guideline in different research settings as well as
compare differences in the results of its methods to see what
works best under different conditions.
Second, the proposed activities can be very thorough and time
consuming. Going through them faster or being less thorough
is an option when time or resources are limiting factors. This
suggests opportunities for future research to determine which
methods are crucial or which can be left out or possible quicker
or discount variants on the methods to find a balance between
investing minimal time and satisfactory results. For example,
it would not make sense to spend a few years researching the
possible relevant stakeholders in a quickly changing
environment like eHealth and technology.
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Finally, this paper was written over time while exploring all
instruments for business modeling, and therefore, our choices
for these instruments were based on our good and bad
experiences and constraints posed by our projects.
Future Research
We applied the business modeling steps in our example case
and also applied them in other projects to test whether they can
be used in various projects. In future road map-related
publications, we plan to further expand on the business modeling
steps and their applications to other eHealth projects. At present,
there is 1 eHealth project on zoonoses that is starting with the
stakeholder identification and analysis steps. In another eHealth
project on dermatology, our business modeling steps are also
applied thoroughly and can be published as a second example
case.
Conclusions
A successful, sustainable implementation of eHealth
technologies is still a tough nut to crack for many eHealth
projects and we believe that more involvement of stakeholders
in the whole development process of eHealth, and not only
designing the actual technology but also designing its
implementation can improve the overall success of the eHealth
project. Having a dialog with stakeholders about their value
expectations will help researchers and developers—as well as
all involved stakeholders—to understand what and why they
are developing eHealth technologies. We hope we can spark
others to work with our proposed guideline, or try stakeholder
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